Evidence map›Paper›PMID 37515274›Full record

ArticleViruses2023

Seroprevalence of Alphaviruses (

Bedia Abdoullah, Guillaume André Durand, Leonardo K Basco, Ahmed El Bara, Mohamed Abdallahi Bollahi, Laurent Bosio, Manon Geulen, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Bedia AbdoullahUnité de Recherche Génomes et Milieux (GEMI), Université de Nouakchott, Nouveau Campus Universitaire, Nouakchott BP 5026, Mauritania.
Guillaume André DurandNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.ORCID 0000-0003-3348-9618
Leonardo K BascoAix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.ORCID 0000-0002-8812-8185
Ahmed El BaraInstitut National de Recherche en Santé Publique, Nouakchott BP 695, Mauritania.
Mohamed Abdallahi BollahiInstitut National de Recherche en Santé Publique, Nouakchott BP 695, Mauritania.
Laurent BosioNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.
Manon GeulenNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.
Sébastien BriolantAix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.ORCID 0000-0001-8872-1774
Ali Ould Mohamed Salem BoukharyUnité de Recherche Génomes et Milieux (GEMI), Université de Nouakchott, Nouveau Campus Universitaire, Nouakchott BP 5026, Mauritania.ORCID 0000-0001-7317-2776
Inserm · FRAix-Marseille Université · FRUniversité de Nouakchott · MR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of alphaviruses, such as chikungunya virus (CHIKV), has never been reported in Mauritania. We assessed the seroprevalence of CHIKV among Nouakchott residents. A cross-sectional study involving 1300 non-febrile patients consulting at the Nouakchott hospital center was conducted between January and June 2021. The presence of anti-CHIKV IgG and neutralizing antibodies against CHIKV, O'nyong-nyong virus (ONNV), and Semliki Forest virus (SFV) was determined by an enzyme-linked immunosorbent assay (ELISA) and a serum neutralization test, respectively, and the associated risk factors were investigated. Of the 1300 study participants, serological evidence of previous exposure to CHIKV was observed in 37 individuals (2.8%). Sex, age, reported use of repellants, and bed net ownership and usage were not associated with CHIKV seropositivity. Our results showed the co-circulation of two other alphaviruses, ONNV and SFV, in Nouakchott in 30 (2.3%) individuals. This is the first study that documents the co-circulation of CHIKV, ONNV, and SFV in Mauritania, albeit at low prevalence. Surveillance and routine testing for alphaviruses and other arboviruses in symptomatic patients should be implemented in health facilities to assess the health burden associated with these viruses. Efforts should also be made to strengthen the vector control measures.

Indexed as

Chikungunya FeverChikungunya virusAfrica, WesternCross-Sectional StudiesHumansMauritaniaO'nyong-nyong VirusSeroepidemiologic StudiesTogaviridaeUrban PopulationalphavirusarboviruschikungunyaELISAMauritanianeutralizationNouakchottO’nyong-nyongSemliki Forestseroprevalence

Identifiers

PMID37515274
PMCPMC10385508
OpenAlexW4385070227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.